2009 Clinical Chemistry Impact Factor [Clinical Chemist]

Written by on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

Important 2010 AACC Election Notice [Clinical Chemist]

Written by on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

Coagulation Cascade: A Series of Limericks [Unveiling the Right Side]

Written by Vande Haar, M. A., Fay, K. A. on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

Detecting Only Light Chains, Now What? [What is your Guess?]

Written by Jacobs, J. F. M., Joosten, I., Klasen, I. S. on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

Research Opportunities for the Clinical Chemist [Clinical Chemist]

Written by on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

Lily Robinson and Ready, On the Set, Go: Recollections [Clinical Chemist]

Written by on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

2010 Consensus Statement on the Worldwide Standardization of the Hemoglobin A1c Measurement [Preamble]

Written by Hanas, R., John, G., on behalf of the International HbA1c Consensus Committee on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

In Reply [Letters to the Editor]

Written by Lenters-Westra, E., Slingerland, R. J. on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

Assessing the Performance of Point-of-Care Hemoglobin A1c Systems [Letters to the Editor]

Written by Irvin, B., Knaebel, J., Simmons, D. on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

The Effect of Sample Hemolysis on Cardiac Troponin I and T Assays [Letters to the Editor]

Written by Bais, R. on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

First- and Second-Trimester ADAM12s in Down Syndrome Screening [Letters to the Editor]

Written by Baviera, G., Chimicata, S., De Domenico, R., Granese, R., Carbone, C., Dugo, N., D'Anna, R. on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

The Osmolal Gap: What Has Changed? [Letters to the Editor]

Written by Whittington, J. E., La'ulu, S. L., Hunsaker, J. J. H., Roberts, W. L. on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

Validity of Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 Measurements in Pancreatic Cyst Fluid with a Serum-Based Immunoassay [Letters to the Editor]

Written by Boot, C. S., Mahon, B. S., Bramhall, S. R., Clark, P. M. on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

Discovery of the Wonder Drug: From Cows to Cortisone [Citation Classic]

Written by Saenger, A. K. on January 1, 1970 – 1:00 am -


Tags: ,
Posted in Clinical Chemistry | Comments Off

C-Reactive Protein Adversely Alters the Protein-Protein Interaction of the Endothelial Isoform of Nitric Oxide Synthase [Brief Communications]

Written by Valleggi, S., Devaraj, S., Dasu, M. R., Jialal, I. on January 1, 1970 – 1:00 am -

BACKGROUND:

C-reactive protein (CRP) inhibits the activity of the endothelial isoform of nitric oxide synthase (eNOS) via uncoupling of the enzyme both in vitro and in vivo. eNOS activity appears to be related in part to its interaction with other cellular proteins, including heat shock protein 90 (Hsp90), caveolin-1, and porin. In this study, we examined the effect of CRP treatment of human aortic endothelial cells (HAECs) on eNOS interaction with caveolin-1, Hsp90, and porin.

METHODS:

We incubated HAECs with CRP (0, 12.5, and 25 mg/L) for 1, 6, or 24 h and assessed the interaction of these proteins with eNOS by immunoprecipitation and western blotting.

RESULTS:

CRP treatment (12.5 and 25 mg/L) of HAECs for 24 h significantly increased eNOS binding to caveolin-1 (40% and 54% increase, respectively; P < 0.05) and decreased binding to Hsp90 (33% and 66% decrease, respectively; P < 0.05). CRP (25 mg/L) also significantly decreased the binding of porin to eNOS (11% decrease, P < 0.05). Similar results were seen when HAECs were treated with CRP for 6 h.

CONCLUSIONS:

These negative protein–protein interactions of eNOS were able to partly explain the CRP-induced decreases in the activity of this critical enzyme, which caused endothelial dysfunction.


Tags: ,
Posted in Clinical Chemistry | Comments Off
RSS